Azor Tablet, Film Coated
NDC Package 0713-0872-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Azor (amlodipine besylate and olmesartan medoxomil) tablets is a medication used to treat high blood pressure (hypertension). This formulation utilizes a tablet, film coated delivery system. Marketed by Cosette Pharmaceuticals, Inc., this product is identified by NDC 0713-0872 and is authorized under FDA application NDA022100.

Identification & Billing

NDC Package Code
0713-0872-30
Package Description
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
0713-0872
11-Digit Billing Format
00713087230
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
  • RxCUI: 730861 - amLODIPine 10 MG / olmesartan medoxomil 20 MG Oral Tablet
  • RxCUI: 730861 - amlodipine 10 MG / olmesartan medoxomil 20 MG Oral Tablet
  • RxCUI: 730861 - amlodipine 10 MG (as amlodipine besylate 13.9 MG) / olmesartan medoxomil 20 MG Oral Tablet
  • RxCUI: 730866 - amLODIPine 10 MG / olmesartan medoxomil 40 MG Oral Tablet
  • RxCUI: 730866 - amlodipine 10 MG / olmesartan medoxomil 40 MG Oral Tablet

Clinical Specifications

Proprietary Name
Azor
Non-Proprietary Name
Amlodipine Besylate And Olmesartan Medoxomil
Substance Name
Amlodipine Besylate; Olmesartan Medoxomil
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This product is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications: amlodipine and olmesartan. They both work by relaxing blood vessels so blood can flow more easily. Amlodipine is a calcium channel blocker and olmesartan is an angiotensin receptor blocker (ARB).

Regulatory & Marketing

Labeler Name
Cosette Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA022100
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0713-0872-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle, plastic of Azor, a human prescription drug labeled by Cosette Pharmaceuticals, Inc.. This tablet, film coated is formulated for oral use and contains amlodipine besylate; olmesartan medoxomil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cosette Pharmaceuticals, Inc. on September 01, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This product is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications: amlodipine and olmesartan. They both work by relaxing blood vessels so blood can flow more easily. Amlodipine is a calcium channel blocker and olmesartan is an angiotensin receptor blocker (ARB).

How is this Cosette Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00713087230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0713-0872-30
11-Digit CMS (5-4-2)
00713-0872-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.